Latest Stories
3 Reasons Investors Love Eli Lilly (LLY)
Eli Lilly currently trades at $1,061 and has been a dream stock for shareholders. It’s returned 541% since December 2020, blowing past the S&P 500’s 85.2% gain. The company has also beaten the index over the past six months as its stock price is up 37.7% thanks to its solid quarterly results.
3 Reasons to Avoid VOYA and 1 Stock to Buy Instead
Voya Financial trades at $75.84 and has moved in lockstep with the market. Its shares have returned 11.5% over the last six months while the S&P 500 has gained 13.4%.
3 Reasons We’re Fans of Datadog (DDOG)
Datadog has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 9.5% to $141.85 per share while the index has gained 13.4%.
3 Reasons RDNT is Risky and 1 Stock to Buy Instead
RadNet currently trades at $74.71 and has been a dream stock for shareholders. It’s returned 305% since December 2020, blowing past the S&P 500’s 85.2% gain. The company has also beaten the index over the past six months as its stock price is up 36.2% thanks to its solid quarterly results.
Assurant (AIZ): Buy, Sell, or Hold Post Q3 Earnings?
Assurant’s 20.9% return over the past six months has outpaced the S&P 500 by 7.5%, and its stock price has climbed to $241.51 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
3 Reasons to Sell OPEN and 1 Stock to Buy Instead
What a time it’s been for Opendoor. In the past six months alone, the company’s stock price has increased by a massive 1,124%, reaching $6.49 per share. This performance may have investors wondering how to approach the situation.
3 Reasons to Sell PAYC and 1 Stock to Buy Instead
Paycom’s stock price has taken a beating over the past six months, shedding 29% of its value and falling to $165.44 per share. This may have investors wondering how to approach the situation.
SiteOne (SITE): Buy, Sell, or Hold Post Q3 Earnings?
Even though SiteOne (currently trading at $127.97 per share) has gained 5.8% over the last six months, it has lagged the S&P 500’s 13.4% return during that period. This might have investors contemplating their next move.
3 Reasons MANH is Risky and 1 Stock to Buy Instead
Over the last six months, Manhattan Associates’s shares have sunk to $176.13, producing a disappointing 8.6% loss - a stark contrast to the S&P 500’s 13.4% gain. This may have investors wondering how to approach the situation.
2 Reasons to Avoid SF and 1 Stock to Buy Instead
Since December 2020, the S&P 500 has delivered a total return of 85.2%. But one standout stock has nearly doubled the market - over the past five years, Stifel has surged 153% to $128.73 per share. Its momentum hasn’t stopped as it’s also gained 29.9% in the last six months thanks to its solid quarterly results, beating the S&P by 16.5%.